Beyond “Seeing is Believing”: MIT Study Reveals the Brain Actively Rewrites Visual Input Based on Mood and Action
By Harshit CAMBRIDGE, MASSACHUSETTS, NOV. 30 —For decades, scientists viewed vision as a primarily bottom-up process: light hits the retina, signals travel to the visual cortex, and the brain forms an image. New research from MIT’s Picower Institute, published in Neuron, fundamentally challenges this model, showing the relationship is a two-way street. The study, led by senior author Professor Mriganka…
Trending News
Death Toll Soars to 417 in Indonesia as Monsoon Flooding Devastates South East Asia
I Tested 5 AI Tools to Automate My Client Intake: Here’s the $49/month Workflow That Passes FTC Compliance
Four Dead, 14 Shot at Child’s Birthday Party in Stockton as Police Search for Gunman
US Halts All Asylum Decisions After DC Shooting as Trump Moves Toward Sweeping Migration Freeze
Editorial picks
Beyond “Seeing is Believing”: MIT Study Reveals the Brain Actively Rewrites Visual Input Based on Mood and Action
Explainable AI (XAI) Requirements for US Financial Lending Algorithms 2026: An E-E-A-T Guide
Pharmacogenomic Testing Validation: Is the FDA Table of Associations Sufficient for US Clinicians?
Beyond “Seeing is Believing”: MIT Study Reveals the Brain Actively Rewrites Visual Input Based on Mood and Action
By Harshit CAMBRIDGE, MASSACHUSETTS, NOV. 30 —For decades, scientists viewed vision as a primarily bottom-up process: light hits the retina, signals travel to the visual cortex, and the brain forms an image. New research from MIT’s Picower Institute, published in Neuron, fundamentally challenges this model, showing the relationship is a…
Four Dead, 14 Shot at Child’s Birthday Party in Stockton as Police Search for Gunman
US Halts All Asylum Decisions After DC Shooting as Trump Moves Toward Sweeping Migration Freeze
Russian Strikes Leave Over 600,000 Without Power in Kyiv Region as Winter Nears
Melania Trump Launches ‘Muse Films’ as New Documentary Set for January Release
Around The World
Pharmacogenomic Testing Validation: Is the FDA Table of Associations Sufficient for US Clinicians?
BY Harshit, 30 NOV 2025 This high-E-E-A-T article is tailored for the US clinical and health-tech audience. It focuses on the critical gap between FDA regulatory labeling and comprehensive clinical practice guidelines, a point of confusion that attracts highly informed, commercially valuable traffic. Pharmacogenomic (PGx) testing promises to end the “trial-and-error” prescribing common in US medicine—particularly for complex conditions like…
Beyond “Seeing is Believing”: MIT Study Reveals the Brain Actively Rewrites Visual Input Based on Mood and Action
By Harshit CAMBRIDGE, MASSACHUSETTS, NOV. 30 —For decades, scientists viewed vision as a primarily bottom-up process: light hits…
Explainable AI (XAI) Requirements for US Financial Lending Algorithms 2026: An E-E-A-T Guide
By Harshit: U.S. AI Compliance Review The era of the “algorithmic black box” in US finance is over….
Pharmacogenomic Testing Validation: Is the FDA Table of Associations Sufficient for US Clinicians?
BY Harshit, 30 NOV 2025 This high-E-E-A-T article is tailored for the US clinical and health-tech audience. It…
